FDA issued a Warning Letter to Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on 7/9/2014 for a previous inspection.
483 Zhejiang Jiuzhou Pharmaceutical Jan 2016

483 Zhejiang Jiuzhou Pharmaceutical Jan 2016

Peter Baker FDA, Christopher Middendorf FDA$119.00 - Available Now

FDA investigators audited the Zhejiang Jiuzhou Pharmaceutical - Taizhou, China facility and issued inspectional observations (via FDA 483) on 23 Jan 2016.

Product details

  • Category: Human Drugs / Animal Drugs & Feeds
  • Inspection end: 23 Jan 2016
  • Location: Taizhou, China
  • FEI: 3003744377
Add To Cart